Testing an Electronic Decision Tool for Pancreatic Cancer Screening Choices
Tests a decision tool to help people at high risk choose pancreatic cancer screening.
Plain-language title generated from the registry record
Registry title: A Decision Support Tool for Pancreatic Cancer Screening -Aim 2
Key facts
- Where
- Chapel Hill, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 99 years old?
Source: NCT07808671, who can take part
Where in United States
- University of North Carolina at Chapel Hill, Department of Gastroenterology and HepatologyChapel Hill, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- UNC Lineberger Comprehensive Cancer Center
- Trial code
- NCT07808671
- Record updated
- 5 November 2026
- Original description
Pancreatic cancer has a rising incidence and poor survival. Early detection in high-risk individuals may substantially improve outcomes. Although guidelines recommend screening for individuals with hereditary cancer syndromes or certain genetic variants, pancreatic cancer screening remains uncertain due to limited evidence of mortality benefit, unclear screening strategies, potential harms, resource requirements, and low adherence. Shared decision-making between patients and providers is therefore essential, but no decision aid currently exists to support pancreatic cancer screening decisions. This record covers Aim 2, which will evaluate the acceptability, feasibility, and implementation of an electronic decision support tool designed to improve shared decision-making, value-concordant care, and screening adherence. The pilot study will also provide training in clinical trial methodology and support development toward an independent research career.Read full original descriptionShow less
A Decision Support Tool for Pancreatic Cancer Screening -Aim 2
Pancreatic cancer has a rising incidence and poor survival. Early detection in high-risk individuals may substantially improve outcomes. Although guidelines recommend screening for individuals with hereditary cancer syndromes or certain genetic variants, pancreatic cancer screening remains uncertain due to limited evidence of mortality benefit, unclear screening strategies, potential harms, resource requirements, and low adherence. Shared decision-making between patients and providers is therefore essential, but no decision aid currently exists to support pancreatic cancer screening decisions. This record covers Aim 2, which will evaluate the acceptability, feasibility, and implementation of an electronic decision support tool designed to improve shared decision-making, value-concordant care, and screening adherence. The pilot study will also provide training in clinical trial methodology and support development toward an independent research career.
Inclusion: Adults who are eligible for pancreatic cancer screening according to current National Comprehensive Cancer Network guidelines; Not currently enrolled in a pancreatic cancer screening program; Referred to or previously seen at the UNC High Risk GI Cancer Clinic; English-speaking; Able and willing to provide informed consent.
Exclusion: Currently enrolled in a pancreatic cancer screening program; Does not meet pancreatic cancer screening eligibility criteria according to National Comprehensive Cancer Network guidelines; Unable or unwilling to provide informed consent; Non-English speaking.